Skip to main content
HR 2792 109th Congress House Health Access to health care Advertising Agriculture and Food Alternative medicine Australia Canada Commerce Communication in medicine Customs unions Deceptive advertising Dietary supplements Drug approvals Drug industry Drug interactions Drugs East Asia Europe European Union Evidence (Law)

Access to Medical Treatment Act

Introduced: June 8, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 17, 2005
Referred to the Subcommittee on Health.
Jun 8, 2005
Introduced in House
Jun 8, 2005
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Access to Medical Treatment Act - Gives an individual the right to be treated by a health care practitioner with any medical treatment that the individual desires, including a treatment that is not approved, certified, or licensed by the Secretary of Health and Human Services, if: (1) the practitioner has personally examined the individual and agrees to treat the individual; and (2) the administration of such treatment does not violate licensing laws.

Authorizes health care practitioners to provide any method of treatment to such an individual if certain requirements are met, including that: (1) there is no reason to conclude that such treatment will cause danger to the individual; and (2) the patient is informed in writing that such treatment has not been approved, certified, or licensed by the Secretary.

Requires a practitioner to report: (1) administering such treatment and discovering it to be a danger to an individual; and (2) the positive effects of an unconventional medical treatment for a life-threatening medical condition.

States that nothing in this Act shall in any way adversely affect the distribution or sale of dietary supplements.

What's happening now June 17, 2005

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 2618 Related bill Access to Medical Treatment Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Independent 1
I
Sanders, Bernard
Vermont · Jul 12, 2005
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2792: Access to Medical Treatment Act. 109th Congress. Open America. https://openamerica.io/bill/109-HR-2792/
MLA
"H.R. 2792: Access to Medical Treatment Act." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-2792/.
Bluebook (legal)
H.R. 2792, 109th Cong. (2026), https://openamerica.io/bill/109-HR-2792/.
Markdown link
[H.R. 2792: Access to Medical Treatment Act](https://openamerica.io/bill/109-HR-2792/)
Report a problem